Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Working Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.551.531.832.303.11

What is the latest Working Capital/Sales ratio of MARKSANS PHARMA ?

The latest Working Capital/Sales ratio of MARKSANS PHARMA is 1.55 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.55
Mar20231.53
Mar20221.83
Mar20212.30
Mar20203.11

How is Working Capital/Sales of MARKSANS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.55
1.31
Mar2023 1.53
-16.39
Mar2022 1.83
-20.43
Mar2021 2.3
-26.05
Mar2020 3.11 -

Other Financial Ratios of MARKSANS PHARMA


Compare Working Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,459.2 Cr -2.8% -13.4% 59.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,135.0 Cr 2.7% 0.9% 34.7% Stock Analytics
DIVIS LABORATORIES ₹153,074.0 Cr -1.1% 1.1% 57.7% Stock Analytics
CIPLA ₹114,019.0 Cr 0.6% -1.7% 8.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,192.0 Cr -1.6% -4.6% 14.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,256.3 Cr -0.5% 2.5% 36% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.8%

-13.4%

59.8%

SENSEX

-0.6%

-2.9%

6.3%


You may also like the below Video Courses